A Dose Range Finding Study to Evaluate the Efficacy and Safety of AZD9668 Administered Orally at Three Dose Levels to Patients With Chronic Obstructive Pulmonary Disease (COPD) on Treatment With Tiotropium

PHASE2CompletedINTERVENTIONAL
Enrollment

838

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

AZD9668

2 x 30 mg oral tablets twice daily (bid) for 12 weeks

DRUG

AZD9668

2 x 10 mg oral tablets twice daily (bid) for 12 weeks

DRUG

AZD9668

2 x 2.5 mg oral tablets twice daily (bid) for 12 weeks

DRUG

AZD9668 Placebo

2 x Matched placebo to oral tablet twice daily (bid) for 12 weeks

Trial Locations (105)

Unknown

Research Site, Fullerton

Research Site, Valparaiso

Research Site, Council Bluffs

Research Site, Hickory

Research Site, Jefferson Hills

Research Site, Gaffney

Research Site, Greenville

Research Site, Spartanburg

Research Site, Boerne

Research Site, Concord

Research Site, Glebe

Research Site, Kogarah

Research Site, Carina Heights

Research Site, Adelaide

Research Site, Daw Park

Research Site, Parkville

Research Site, Nedlands

Research Site, Edmonton

Research Site, Vancouver

Research Site, Mount Pearl

Research Site, Antigonish

Research Site, Grimsby

Research Site, Hamilton

Research Site, Kingston

Research Site, Mississauga

Research Site, Toronto

Research Site, La Malbaie

Research Site, Mirabel

Research Site, Québec

Research Site, Saint-Léonard

Research Site, Saskatoon

Research Site, Berlin

Research Site, Fulda

Research Site, Hanover

Research Site, Leipzig

Research Site, Marburg

Research Site, Seto

Research Site, Noda

Research Site, Touon

Research Site, Fukuoka

Research Site, Yukuhashi

Research Site, Nihommatsu

Research Site, Hiroshima

Research Site, Asahikawa

Research Site, Sapporo

Research Site, Himeji

Research Site, Kagoshima

Research Site, Kawasaki

Research Site, Yokohama

Research Site, Kochi

Research Site, Ukyo-ku, Kyoto

Research Site, Matsumoto

Research Site, Saiki

Research Site, Kishiwada

Research Site, Kita-ku, Sakai

Research Site, Matsue

Research Site, Chūō

Research Site, Nakano-ku

Research Site, Tanabe

Research Site, Bunkyō City

Research Site, Iloilo City

Research Site, Lipa City, Batangas

Research Site, Quezon City

Research Site, Bydgoszcz

Research Site, Chęciny

Research Site, Krakow

Research Site, Ostrów Wielkopolski

Research Site, Poznan

Research Site, Proszowice

Research Site, Tczew

Research Site, Wroclaw

Research Site, Zawadzkie

Research Site, Barnaul

Research Site, Kazan'

Research Site, Moscow

Research Site, Novosibirsk

Research Site, Saint Petersburg

Research Site, Yekaterinburg

Research Site, Bardejov

Research Site, Bojnice

Research Site, Bratislava

Research Site, Košice

Research Site, Nové Mesto nad Váhom

Research Site, Nové Zámky

Research Site, Poprad

Research Site, Prešov

Research Site, Trnava

Research Site, Zvolen

Research Site, Žilina

Research Site, Wŏnju

Research Site, Uijeongbu-si

Research Site, Anyang

Research Site, Bucheon-si

Research Site, Daegu

Research Site, Seoul

Research Site, Kaohsiung City

Research Site, Keelung

Research Site, Taichung

Research Site, Taipei

Research Site, Taoyuan District

Research Site, Ivano-Frankivsk

Research Site, Luhansk

Research Site, Dnipropetrovsk

Research Site, Kharkiv

Research Site, Kyiv

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY